8-KRegulation FDExhibits & Filings

Merck & Co., Inc. 8-K Report, Regulation FD Disclosure (Sep 10, 2007)

Filed September 10, 2007For Securities:MRK

Summary

Merck & Co., Inc. (MRK) has filed a Current Report on Form 8-K dated September 10, 2007, primarily to furnish Frequently Asked Questions and Answers (FAQs) issued by Schering-Plough Corporation. These FAQs, dated September 10, 2007, are presented as Exhibit 99.1 and are available on Schering-Plough's investor relations website. Investors interested in Schering-Plough's perspective on various matters should refer to these FAQs. Merck's filing serves as a conduit to disseminate this information to its stakeholders.

Key Highlights

  • 1Merck is furnishing Schering-Plough's September 10, 2007, FAQs as Exhibit 99.1 to this 8-K filing.
  • 2The FAQs are intended to address investor inquiries and are available on Schering-Plough's corporate website.
  • 3This filing does not contain new financial statements or exhibits beyond the referenced FAQs.
  • 4Investors are advised to consult the FAQs for information directly from Schering-Plough.
  • 5Schering-Plough explicitly states no obligation to update the provided FAQs.
  • 6The filing date is September 10, 2007, and the event date is September 9, 2007.

Frequently Asked Questions

The primary purpose of this Merck 8-K filing is to furnish Frequently Asked Questions and Answers (FAQs) that were issued by Schering-Plough Corporation on September 10, 2007. Merck is making these Schering-Plough FAQs available to investors as Exhibit 99.1.

The Schering-Plough FAQs, dated September 10, 2007, are available on the Schering-Plough Corporation website at www.schering-plough.com under the “Investor Relations/Investor FAQs” section. They are also furnished as Exhibit 99.1 to this Merck 8-K filing.

No, this filing does not contain any new financial statements or operational updates from Merck & Co., Inc. It solely serves to disseminate the Schering-Plough FAQs.

The filing itself does not specify the exact nature of the relationship that necessitates Merck furnishing Schering-Plough's FAQs. However, the context of Regulation FD Disclosure suggests it's to ensure broad public access to information that might be of interest to investors concerning Schering-Plough.